Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
David S. Majdalany, MD, is a staff physician specializing in adult congenital heart disease in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute and a member of the Adult Congenital Heart Center. He is board-certified in internal medicine, general cardiology, nuclear cardiology, and echocardiography.
Dr. Majdalany is a graduate of the Marshall University School of Medicine, in Huntington, W.Va. He completed a combined residency in internal medicine and pediatrics at Mount Sinai Medical Center in New York City followed by a fellowship in adult cardiology at the University of Louisville School of Medicine in Louisville, Ky. He subsequently completed a fellowship in advanced echocardiography at Columbia University Medical Center before relocating to Rochester, Minn. for fellowships in adult congenital heart disease and critical care medicine at Mayo Clinic. He joined Cleveland Clinic in 2010 upon completion of this subspecialty training.
While a fellow at the Mayo Clinic Dr. Majdalany was involved in a number of research projects related to adult congenital heart disease, including imaging and surgical repair and outcomes. Prior to that, he participated in several research projects at the University Of Louisville School Of Medicine, Columbia University School of Medicine, and the Mount Sinai Medical Center.
Dr. Majdalany has co-authored papers on outcomes and imaging in patients with surgically corrected adult congenital heart defects that have been published in or submitted to leading medical journals. He also has been a presenter on these topics at meetings of the Adult Congenital Heart Association, the American College of Cardiology and the American Heart Association Scientific Sessions.
His professional memberships include the International Society of Adult Congenital Heart Disease, the Adult Congenital Heart Association, the American College of Cardiology, the American Heart Association, the American Society of Nuclear Cardiology, and the American Society of Echocardiography.
Adult congenital heart disease, general cardiology, catheter repair procedures for congenital heart disease
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/10/2015, Dr. Majdalany has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.